2018 STOFF
2018 STOFF Agenda (PDF)
Presentation Summaries

Bruce A. Chabner, MD
Massachusetts General Hospital Cancer Center,
Boston, Massachusetts, USA
Massachusetts General Hospital Cancer Center,
Boston, Massachusetts, USA

Susan Hilsenbeck, PhD
Baylor College of Medicine,
Houston, Texas, USA
Baylor College of Medicine,
Houston, Texas, USA

Stacey Berg, MD
Texas Children’s Cancer Center, Texas Children’s Hospital,
Baylor College of Medicine, Houston, TX, USA
Texas Children’s Cancer Center, Texas Children’s Hospital,
Baylor College of Medicine, Houston, TX, USA

Bernardo H.L. Goulart, MD, MS
University of Washington
Seattle Cancer Care Alliance, Seattle, Washington, USA
University of Washington
Seattle Cancer Care Alliance, Seattle, Washington, USA

Keith Flaherty, MD
Massachusetts General Hospital Cancer Center,
Boston, Massachusetts, USA
Massachusetts General Hospital Cancer Center,
Boston, Massachusetts, USA

Ross Levine, MD
Memorial Sloan Kettering Cancer Center,
New York, New York, USA
Memorial Sloan Kettering Cancer Center,
New York, New York, USA

Tatiana Prowell, MD
City of Hope Comprehensive Cancer Center,
Duarte, California, USA
City of Hope Comprehensive Cancer Center,
Duarte, California, USA

Mark W. Duncan, PhD
University of Colorado,
Denver, Colorado, USA
University of Colorado,
Denver, Colorado, USA

Kiran Patel, MD
Janssen Research & Development, LLC,
Raritan, New Jersey, USA
Janssen Research & Development, LLC,
Raritan, New Jersey, USA

Michael Maitland, MD
Schar Cancer Institute, Inova Health System,
Annandale, Virginia, USA
Schar Cancer Institute, Inova Health System,
Annandale, Virginia, USA

Kerry Reynolds, MD
Massachusetts General Hospital Cancer Center,
Boston, Massachusetts, USA
Massachusetts General Hospital Cancer Center,
Boston, Massachusetts, USA

Carlos Ramos, MD
Cleveland Clinic,
Cleveland, Ohio, USA
Cleveland Clinic,
Cleveland, Ohio, USA

Ryan Corcoran, MD, PhD
Massachusetts General Hospital Cancer Center,
Boston, Massachusetts, USA
Massachusetts General Hospital Cancer Center,
Boston, Massachusetts, USA

Neil Hayes, MD
University of Tennessee Health Science Center,
Germantown, Tennessee, USA
University of Tennessee Health Science Center,
Germantown, Tennessee, USA
Acknowledgments
This activity is sponsored by the Society for Translational Oncology. STO gratefully acknowledges the support of the 2018 Fellows’ Forum from:
- Amgen
- Janssen
- CHAAO